Allianz Asset Management
AGTC

Allianz Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Allianz Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-40,820
Closed -$282K – 2709
2017
Q1 		$282K Buy
40,820
+3,945
+11% +$30.8K ﹤0.01% 2499
2016
Q4 		$345K Sell
36,875
-41,765
-53% -$376K ﹤0.01% 2436
2016
Q3 		$769K Sell
78,640
-5,200
-6% -$70.1K ﹤0.01% 2278
2016
Q2 		$1.19M Buy
83,840
+33,065
+65% +$516K ﹤0.01% 2122
2016
Q1 		$710K Buy
+50,775
New +$745K ﹤0.01% 2181

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Numeric Investors
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management's AGTC Position: Q2 2017 in Review

Allianz Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 40,820 shares — an estimated $282K sold.

Allianz Asset Management first reported a position in AGTC in Q1 2016 and held it in 5 quarters. The position peaked at $1.19M in Q2 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • Allianz Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • Allianz Asset Management sold 40,820 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $282K.
  • Allianz Asset Management first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 5 quarters.
  • Allianz Asset Management's Applied Genetic Technologies Corporation position peaked at $1.19M in Q2 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on Allianz Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.